Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

The prevalence of cancer as a threat to human life, responsible for 9.6 million deaths worldwide in 2018, motivates the search for new anticancer agents. While many options are currently available for treatment, these are often expensive and impact the human body unfavourably. Anticancer peptides represent a promising emerging field of anticancer therapeutics, which are characterized by favourable toxicity profile. The development of accurate in silico methods for anticancer peptide prediction is of paramount importance, as the amount of available sequence data is growing each year. This study leverages advances in machine learning research to produce a novel sequence-based deep neural network classifier for anticancer peptide activity. The classifier achieves performance comparable to the best-in-class, with a cross-validated accuracy of 98.3%, Matthews correlation coefficient of 0.91 and an Area Under the Curve of 0.95. This innovative classifier is available as a web server at, facilitating in silico screening and design of new anticancer peptide chemotherapeutics by the research community.

Timmons Patrick Brendan, Hewage Chandralal M


Anticancer drugs, In silico screening, Machine learning, Neural network, Peptides